Virtu Financial’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,203
Closed -$32K 2282
2022
Q4
$32K Buy
2,203
+1,753
+390% +$33.8K ﹤0.01% 1168
2022
Q3
$11K Sell
450
-3
-0.7% -$77 ﹤0.01% 1513
2022
Q2
$9K Sell
453
-200
-31% -$4.44K ﹤0.01% 1435
2022
Q1
$23K Buy
+653
New +$24.3K ﹤0.01% 1277
2021
Q4
Sell
-1,315
Closed -$94K 2289
2021
Q3
$94K Buy
+1,315
New +$150K 0.01% 1162
2021
Q2
Sell
-1,550
Closed -$208K 2188
2021
Q1
$208K Buy
1,550
+1,203
+347% +$152K 0.01% 1067
2020
Q4
$26K Buy
+347
New +$25.5K ﹤0.01% 1334
2019
Q4
$110K Buy
+1,360
New +$97.1K 0.01% 1066

Other funds holding ASLN

Virtu Financial's ASLN Position: Q1 2023 in Review

Virtu Financial sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2023, closing a stake of 2,203 shares — an estimated $32K sold.

Virtu Financial first reported a position in ASLN in Q4 2019 and held it in 8 quarters. The position peaked at $208K in Q1 2021. 16 funds tracked by Wall St. Rank hold ASLN as of Q1 2023.

  • Virtu Financial reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Virtu Financial sold 2,203 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2023, an estimated $32K.
  • Virtu Financial first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2019 and held it in 8 quarters.
  • Virtu Financial's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $208K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.